Light gray square, with a dark gray border on the sides.

Blog

The Unified Cardiac Workflow: Bridging the Gap Between Anatomy, Function, and Inflammation

March 12, 2026

The Clinical Challenge & the cvi42 Solution


Executive Summary


Cardiovascular disease remains the leading cause of global mortality, yet diagnostic workflows remain fragmented. Traditionally, clinicians have been forced to navigate disconnected systems to assess a patient’s heart: one for anatomy (CCTA), another for function (CMR/Strain), and a third for vascular inflammation (PCAT/Plaque). This "siloed" approach creates diagnostic friction, increases costs, and delays life-saving interventions.

An infographic titled Triple Threat displaying three shields: an anatomical heart, a clock on a heart, and a heart in flames.

cvi42 by Circle Cardiovascular Imaging disrupts this paradigm. It is the industry’s first unified platform capable of reading Cardiac MRI and Cardiac CT, including AI-enabled Plaque and research-use PCAT analysis, within a single application. By combining Anatomy + Function + Inflammation, cvi42 provides a holistic view of patient health in one seamless workflow.

The Physician Perspective: Precision and Autonomy


For the radiologist and cardiologist, the transition to a unified platform offers three primary advantages:


  1. Elimination of Diagnostic "Blind Spots": Traditional CCTA identifies stenosis (anatomy) but often fails to identify the vulnerability of a lesion. By integrating Plaque Analysis and PCAT (Pericoronary Adipose Tissue), physicians can identify active inflammation—the "hidden" driver of rupture—without leaving the workspace.

  2. Workflow Continuity and Reduced Burnout: Jumping between disconnected systems leads to "swivel-chair" medicine. cvi42 integrates directly into existing PACS and reporting systems (like PowerScribe One) without expensive HL7 interface, allowing for high-throughput analysis that reduces the time from "scan to report".

  3. Financial Sustainability and Reimbursement: With the 2026 transition to a Category I CPT code (75577) for AI-enabled quantitative plaque analysis, hospitals can now retain 70% of the technical and professional reimbursement fee. cvi42 enables the facility to perform these advanced analytics in-house, rather than outsourcing to costly third-party core labs who retain most of the reimbursement.


The Patient Impact & Strategic Outlook


The Patient Perspective: Safety and Certainty


From the patient's point of view, the diagnostic journey is often fraught with anxiety and repetitive testing. A unified workflow changes the experience fundamentally:


  • The "One and Done" Experience: By assessing anatomy, function, and inflammation in a single sitting, patients avoid the "diagnostic odyssey" of stressful weeks spent waiting for multiple follow-up tests.
  • Early Detection of the "Hidden" Risk: Many patients who appear "low risk" on standard CT scans harbor high levels of vascular inflammation. cvi42’s research capabilities—such as the analysis of pericoronary adipose tissue (PCAT) allows researchers to better understand these risks. This work is essential in the shift from reactive surgery to proactive prevention.
  • Personalized Clinical Clarity: A patient is more likely to adhere to a treatment plan (statins, lifestyle changes) when they can see a unified, color-coded map of their own heart's health. cvi42 provides the visual evidence needed to drive patient compliance and trust.



Strategic Value for the Healthcare System


In a value-based care environment, the "All-in-One" approach of cvi42 serves the Quadruple Aim:

1. Lower Costs: Reducing redundant imaging and unnecessary invasive catheterizations.

2. Better Outcomes: Comprehensive results to inform diagnoses.

3. Improved Patient Experience: Faster answers and less travel between specialists.

4. Provider Satisfaction: A modern, intuitive toolset that works at the speed of the clinician.

A quadrant infographic showing

cvi42 empowers the clinical team to see the whole picture of Anatomy, Function, and Inflammation all in one place. This isn't just a software upgrade; it is a new standard of care for the modern heart center.


Strategic Financial Analysis: The Imaging Department & CFO Perspective


For an imaging department, by consolidating Anatomy, Function, and Inflammation into a single on-premise application, the institution secures immediate financial advantages through new reimbursement streams and significant operational efficiencies.


Revenue Capture: The 70% Retention Model



The primary financial catalyst is the 2026 activation of Category I CPT codes for AI-enabled quantitative plaque analysis. While traditional outsourcing models often result in the loss of technical fees to third-party labs, the cvi42 on-premise solution allows the hospital to maintain a commanding share of the revenue.


A table showing CPT code 75577 for AI-enabled coronary plaque analysis with a $1,015 reimbursement and $710 net retention.

By keeping these advanced analytics in-house, the facility avoids the high costs of third-party processing, ensuring that approximately 70% of the total reimbursement remains within the hospital's bottom line.


Performance Improvements & Capacity Expansion


The unified workflow directly addresses "swivel-chair" medicine, where clinicians lose productive time navigating disconnected systems.

Infographic showing ROI of cvi42 cardiac software: revenue retention, efficiency gains, capacity expansion, and Quadruple Aim.

Reduction in Analysis Time: Integrated reporting and automated AI tools reduce the time from "scan to report".

Expansion of Patient Capacity: The facility can treat more patients without increasing headcount.

Reduced Diagnostic Friction: Reduces the administrative burden of scheduling multiple follow-up tests, further lowering the cost per patient.

Enhanced Provider Retention: Providing a modern, intuitive toolset that works at the "speed of the clinician" mitigates burnout, a major indirect cost for healthcare systems.

Summary of Strategic Financial Value



A table titled

The future of cardiac care isn't just about faster software; it’s about providing a clearer picture of patient risk when it matters most. By bridging the gap between anatomy, function, and inflammation, cvi42 empowers clinicians to move beyond simple detection toward true prevention. As we transition into this new era of AI-enabled diagnostics and standardized reimbursement, the unified workflow stands as the new gold standard for heart health—transforming complex data into life-saving clinical confidence.

A medical professional in a navy blue scrub top points to heart scan imagery on a monitor while consulting a colleague.
May 12, 2026
The Effort, Risks, and Why It’s Worth It Quantifying the Effort of a Single Platform Learning a new (or deeper) way of working Even for existing cvi 42 users, full standardization across cardiac imaging means: Adapting to new modules or modalities. Rethinking how you structure reading lists when more work is visible in one place. Helping develop shared templates and protocols. It’s completely normal to see a temporary dip in productivity when something new is introduced. Our brains are wired for loss aversion: we tend to focus more on what we might lose than on what we could gain. Recognizing that bias helps put the slowdown in perspective: it’s not a setback, it’s just part of the process that leads to long‑term progress. 
Secure data within the cvi42 cardiovascular imaging application for AI enabled postprocessing
May 5, 2026
Local Processing for Complete Data Security When cvi 42 processes imaging data, everything takes place within the customer’s secure environment. All image data and derived results are managed locally, whether on a hospital workstation or through a customer-managed server installation. No data is ever transmitted outside the institution. This architecture ensures compliance with strict hospital IT policies and data protection frameworks. For clinical users, this means AI-powered results without any compromise to data privacy or network security. The Circle AI Engine: Trained, Validated, and Frozen “Each of the AI models powering cvi42 is architected and developed within Circle’s controlled research and development environment. Circle’s data science and clinical AI research teams use diverse and representational datasets to train and validate each algorithm. The process typically involves supervised learning, where the AI learns to recognize patterns and structures such as the left ventricle, myocardium, or aortic root by comparing its results to expert-annotated data. Once performance meets clinical and regulatory standards, the AI model is locked, “frozen” and encrypted during its integration within cvi42. This means the model’s behavior is fixed, it does not continue to learn or change once deployed at a customer site. The model you use in cvi 42 is the validated version approved for clinical use, ensuring consistent and reproducible results across all installations. No Learning from Customer Data It is important to clarify: the AI in cvi 42 does not learn from any data processed at the customer site. The algorithm applies its pre-trained parameters to each image set locally. It does not store patient data, send information externally, or modify its internal model based on what it sees or whether a user edits its outputs. Each analysis is isolated, ensuring the AI’s decisions remain consistent and the patient’s information stays protected within the facility’s network. How the AI Analyzes Medical Images At a technical level, cvi42’s AI is a deep learning-based image analysis engine trained to recognize and segment cardiac anatomy on MR and CT images. Primarily using convolutional neural networks, it performs pixel- or voxel-level classification to delineate key structures, including the endocardial and epicardial borders. These segmentations enable the measurements of clinically relevant metrics such as chamber volumes, ejection fraction, and myocardial mass. This process mimics how expert readers would interpret the same dataset, but it happens in seconds and with objective consistency across cases. Designed for Trust, Built for Performance AI in cvi 42 is designed to automate routine analysis while keeping clinicians fully in control. Users can review, adjust, and approve AI-generated contours as needed, ensuring that results always meet their clinical standards. Combined with local data processing, frozen AI models, and Circle’s rigorous training pipeline, this approach delivers accuracy and reliability without ever compromising patient privacy.
A healthcare worker in a white coat juggles colorful balls in a hospital corridor, with staff and a patient nearby.
March 23, 2026
Clinical Wins and Daily Practice Introduction A single cardiovascular imaging platform like Circle’s cvi 42 changes daily work for cardiologists and radiologists from “tool juggling” to focused clinical practice. But it also asks for effort and carries real, though manageable, risks. Seeing this change from your perspective, the people interpreting images and shaping programs, makes it easier to decide whether adopting a unified platform is worthwhile.
Patient in a hospital gown lies on a CT scanner bed, nurse smiles and comforts him. White and gray machine, neutral setting.
March 17, 2026
For years, the Coronary Artery Calcium (CAC) score has been the gold standard for a quick, non-invasive look at heart disease risk. It’s a vital tool that has helped millions of patients understand if they have "hardening of the arteries." But while a calcium score tells us that plaque is present, it only tells part of the story. As medical technology evolves, we are moving beyond simply identifying the presence of calcium to a much more detailed understanding of heart disease. With the advent of AI-enabled coronary plaque analysis, such as cvi42 | Plaque , patients and physicians now have access to a deeper level of insight that was previously impossible to achieve through standard screening alone. What is AI-Enabled Coronary Plaque Analysis? While a traditional calcium score measures the amount of mineralized (hard) plaque in your coronary arteries, AI-enabled plaque analysis looks at the "soft" or non-calcified plaque as well.

Subscribe to our newsletter

 Don’t miss future articles or publications.